March 25 (Reuters) – U.S. Food and Drug Administration staff members said on Friday Acadia Pharmaceuticals Inc’s drug to treat psychosis associated with Parkinson’s disease was an effective treatment…
The post UPDATE 1-FDA staff says Acadia’s drug for Parkinson’s disease psychosis is effective appeared first on NASDAQ.